Meet the Man Who Has Led 2018 in Multiple Sclerosis Research
His work as also created further understanding of more severe MS damage
Barkhof is also leading the use of measurements to pinpoint “black hole” lesions, which are areas of fairly severe tissue damage. These lesions show up differently on MRIs (as darker spots) and they are considered to be independent neurodegenerative markers of the disease. “His insights have greatly contributed to modern trial design and therapeutics, which is now propelling the field in important and increasingly focused directions,” wrote Jerry S. Wolinsky, Professor Emeritus in the Department of Neurology at the McGovern Medical School.